Method for the spectroscopic determination of the oxygen saturation of blood in the presence of optical disturbance variables
Abstract
Method for determining the oxygen saturation of blood in the presence of optical disturbances, in particular by means of a biological tissue surrounding the blood vessel and / or the blood or the blood vessel itself, in which spectral measurement values (Mi) for hemoglobin (Hb) and oxyhemoglobin (HbO2) isosbestic wavelengths and at least one other measured value (Ma) at a wavelength at which the reference values of hemoglobin and oxyhemoglobin differ, and are compared with known reference values of the reference spectra of hemoglobin and oxyhemoglobin, characterized in that a) that at least two said spectral measurement values (Mi1, Mi2), at isosbestic wavelengths for hemoglobin and oxyhemoglobin (λi1, λi2) and at least the other measured value (Ma) at a wavelength (λa), in which the reference values of hemoglobin and oxyhemoglobin differ as far as possible in the reference spectra, are recorded logarithmically, with at least two of the measured values (Mi1, Mi2) for isosbestic wavelengths (λi1, λi2) a linear auxiliary function (FH) is generated ...

Term
Term ended
Expired 17 April 2022, 4.4 years ago.
- Priority and filed
- Granted
- Expired
- Today
3 claims: 1 independent, 2 dependent
- 1Verfahren zur Bestimmung der Sauerstoffsättigung von Blut in Gegenwart optischer Störgrößen, insbesondere durch ein das Blutgefäß umgebendes biologisches Gewebe und/oder des Blutes bzw. des Blutgefäßes selbst, bei dem durch Transmissions- bzw. Reflexionsmessung in einem Mess-Spektrum spektrale Messwerte (M i ) bei für Hämoglobin (Hb) und Oxihämoglobin (HbO 2 ) isosbestischen Wellenlängen und mindestens ein anderer Messwert (M a ) bei einer Wellenlänge, bei welcher sich die Referenzwerte von Hämoglobin und Oxihämoglobin unterscheiden, erzeugt sowie mit bekannten Referenzwerten der Referenz-Spektren von Hämoglobin und Oxihämoglobin verglichen werden, dadurch gekennzeichnet , a) dass in dem Mess-Spektrum zumindest zwei besagte spektrale Messwerte (M i1 , M i2 ), bei für Hämoglobin und Oxihämoglobin isosbestischen Wellenlängen (λ i1 , λ i2 ) und zumindest der andere Messwert (M a ) bei einer Wellenlänge (λ a ), bei welcher sich die Referenzwerte von Hämoglobin und Oxihämoglobin in den Referenz-Spektren möglichst weitgehend unterscheiden, logarithmisch erfasst werden, wobei zumindest aus zwei der Messwerte (M i1 , M i2 ) für isosbestische Wellenlängen (λ i1 , λ i2 ) eine lineare Hilfsfunktion (F H ) generiert wird, b) dass in den Referenz-Spektren aus den mit den für dieselben isosbestischen Wellenlängen (λ i1 , λ i2 ) des Hämoglobins und Oxihämoglobins der im Mess-Spektrum ermittelten zumindest zwei Messwerte (M i1 , M i2 ) korrespondierenden Referenzwerten (R i1 , R i2 ) eine lineare Referenzfunktion (F R ) generiert wird, c) dass aus der Hilfsfunktion (F H ) des Mess-Spektrums, auf welcher die besagten zumindest zwei Messwerte (M i1 , M i2 ) für isosbestische Wellenlängen (λ i1 , λ i2 ) liegen und aus der Referenzfunktion (F R ) der Referenz-Spektren, auf welcher die zu den zumindest zwei Messwerte (M i1 , M i2 ) korrespondierenden zumindest zwei Referenzwerte (R i1 , R i2 ) liegen eine lineare Korrekturfunktion (F K ) gebildet wird, mit welcher in einem korrigierten Mess-Spektrum eine ebenfalls lineare korrigierte Hilfsfunktion (F Hk ) erzeugt wird, die mit der Referenzfunktion (F R ) in den Referenz-Spektren identisch ist und d) dass die Sauerstoffsättigung des Blutes aus dem auf die korrigierte Hilfsfunktion (F Hk ) des korrigierten Mess-Spektrums umgerechneten anderen Messwert (M a '') in Relation zu den Referenzwerten für Hämoglobin und Oxihämoglobin bei dieser Wellenlänge (λ a ) ermittelt wird.
- 2Verfahren nach Anspruch 1, dadurch gekennzeichnet, a) dass drei besagte spektrale Messwerte (M i1 , M i2 , M i3 ) bei für Hämoglobin und Oxihämoglabin isosbestischen Wellenlängen (λ i1 , λ i2 , λ i3 ) und ein anderer Messwert (M a ) bei einer Wellenlänge (λ a ), bei welcher sich die Referenzwerte von Hämoglobin und Oxihämoglobin in den Referenz-Spektren möglichst weitgehend unterscheiden, logarithmisch erfasst werden, wobei aus zwei logarithmischen Messwerten (M i1 , M i2 ) für isosbestische Wellenlängen (λ i1 , λ i2 ) eine lineare Hilfsfunktion (F H ) generiert wird, b) dass in den Referenz-Spektren aus den mit den für dieselben isosbestischen Wellenlängen (λ i1 , λ i2 ) des Hämoglobins und Oxihämoglobins der im Mess-Spektrum ermittelten Messwerte (M i1 , M i2 ) korrespondierenden Referenzwerten (R i1 , R i2 ) eine ebenfalls lineare Referenzfunktion (F R ) generiert wird, c) dass aus der Hilfsfunktion (F H ) des Mess-Spektrums und aus der Referenzfunktion (F R ) der Referenz-Spektren eine lineare Korrekturfunktion (F K ) gebildet wird, mit welcher im korrigierten Mess-Spektrum eine ebenfalls lineare korrigierte Hilfsfunktion (F Hk ) erzeugt wird, die mit der linearen Referenzfunktion (F R ) in den Referenz-Spektren identisch ist, d) dass die übrigen korrigierten spektralen Messwerte, d. h. der dritte spektrale Messwert (M i3 ') bei für Hämoglobin und Oxihämoglobin isosbestischer Wellenlänge (λ i3 ) und der andere Messwert (M a ') bei einer Wellenlänge (λ a ), bei welcher sich die Referenzwerte von Hämoglobin und Oxihämoglobin in den Referenz-Spektren möglichst weitgehend unterscheiden, mit einem konstanten Multiplikator beaufschlagt werden, welcher so bestimmt wird, dass der hierdurch korrigierte dritte spektrale Messwert (M i3 '') des korrigierten Mess-Spektrums mit dem korrespondierenden Referenzwert der Referenz-Spektren übereinstimmt und e) dass die Sauerstoffsättigung des Blutes an dem auf die korrigierte Hilfsfunktion (F Hk ) des korrigierten Mess-Spektrums umgerechneten anderen Messwert (M a '') auf einer durch die Referenzwerte für Hämoglobin und Oxihämoglobin bei dieser Wellenlänge (λ a ) aufgespannten Skala von 0 bis 1 abgelesen wird.
- 3Verfahren nach Anspruch 1, dadurch gekennzeichnet, dass zur zweidimensionalen Darstellung der Sauerstoffsättigung des Blutes vier monochromatische Einzelbilder der spektralen Messwerte (M i , M a ) erzeugt werden und dass die Sauerstoffsättigung gemäß der Schritte a) bis d) für jeden Bildpunkt ermittelt wird.
Independent claims3
20 paragraphs, as filed
The invention relates to a method for the spectrometric determination of the oxygen saturation of blood in the presence of optical disturbances, such as those that also form pigmented and light-scattering surrounding tissue and / or the blood vessel wall itself. This problem of determining oxygen saturation of blood as possible without the influence of these factors influencing the measurement accuracy occurs in particular in the case of non-invasive in vivo or in vitro examinations of blood vessels which lie in front of, behind or in said pigmented and scattering tissue, for example the examination of blood vessels in the fundus of the eye or other tissue areas of the body, such as the skin and organs accessible by endoscopy.
It is generally known that the absorption spectrum of the red blood pigment hemoglobin changes with oxygen saturation (for example van Assendelft OW, Spectrophotometry of heamoglobin derivatives, Assen: Royal Vangorcum, 1970). This makes it possible to determine the oxygen saturation of a hemoglobin sample by comparing the spectrum of the sample with the spectra of completely oxygenated and completely reduced hemoglobin.
Recent work on oximetry at the back of the eye according to the Lambert-Beers law, ie taking only absorption into account, is by Smith et al (Smith MH, Denninghoff KR, Lompado A., Hillman LW, Effect of multiple light paths in retinal vessel oximetry, Appl. Opt. 39, 2000, 1183-1193). Numerous patented arrangements and procedures are based on this principle (for example<de-docref CY="US" DNUM="4485820">US 4,485,820</de-docref>; <de-docref CY="US" DNUM="5119814">US 5,119,814</de-docref>; <de-docref CY="US" DNUM="5308919">US 5,308,919</de-docref>; <de-docref CY="US" DNUM="4253744">US 4,253,744</de-docref>; <de-docref CY="US" DNUM="4305398">US 4,305,398</de-docref>; <de-docref CY="US" DNUM="5776060">US 5,776,060</de-docref>; <de-docref CY="US" DNUM="5935076">US 5,935,076</de-docref><de-docref CY="DE" DNUM="19920157" KI="A1">DE 199 20 157 A1</de-docref>; <de-docref CY="US" DNUM="5318022">US 5,318,022</de-docref>). In the in vivo measurement, however, the hemoglobin is not isolated, but is included in the erythrocytes. The scattering of light on the erythrocytes has a significant influence on the absorbance spectrum of the blood. According to the results of Twersky's multiple scattering theory (Twersky V., Absorption and multiple scattering by biological suspensions, J. Opt. Soc. Amer. 60, 1970, 1084-1093), the influences of scattering and absorption can be separated. On this basis, Pittman and Duling have described a method that determines the oxygen saturation in whole blood from measurements carried out in transmission at the wavelength 555 nm and at the isosbestic points at 522 nm and 546 nm (Pittman RN, Duling BR. A new method for the measurement of percent oxyhemoglobin. J. Appl. Physiol. 38, 1975, 315-320). This method has been used by Delori to determine oxygen saturation in retinal vessels (Delori F. C., Noninvasive technique for oximetry of blood in retinal vessels. Appl. Opt, 27, 1988, 113-1125).
However, studies by Hammer et al (Hammer M., Leistritz S., Leistritz L., Schweitzer D., Light paths in retinal vessel oxymetry, IEEE Trans Biomed Eng 48 (5), 2001, 592-8) show that the Reflection spectra measured in retinal vessels are influenced not only by the absorption of hemoglobin and the scatter in the blood and the tissue surrounding the vessels, but also by the melanin localized in the retinal pigment epithelium and in the choroid. The same applies to vessels in the skin or other pigmented organs.
The correction of the falsification of the hemoglobin spectra by other chromophores and their correction for spectroscopic oximetry has been attempted in the previous literature by standardizing the spectra measured on a vessel to measurements next to the vessel (e.g. <de-docref CY="DE" DNUM="19920157" KI="A1">DE 199 20 157 A1</de-docref>; <de-docref CY="US" DNUM="5935076">US 5,935,076</de-docref>; Delori FC, Noninvasive technique for oximetry of blood in retinal vessels. Appl. Opt. 27, 1988, 113-1125; Schweitzer D., Hammer M., Kraft J., Thamm E., Königsdörffer E., Strobel J., In Vivo Measurement of the Oxygen Saturationm at the Normal Human Eye, IEEE Trans. Biomed. Closely. 46, 1999, 1454-1465). However, this approach leaves the extremely complicated relationships (Hammer M., Leistritz S., Leistritz L., Schweitzer D., Light paths in retinal vessel oxymetry, IEEE Trans Biomed Eng 48 (5), 2001, 592–8) of the radiation propagation in the Disregard the blood vessel and the surrounding tissue.
The exact spread of light in the biological tissue can still not be completely described physically. Even efforts to comprehend these processes for eliminating disturbance variables as comprehensively and as realistically as possible (<de-docref CY="DE" DNUM="19920157" KI="A1">DE 199 20 157 A1</de-docref>) and to model the optics of the living or dead biological tissue surrounding the blood vessels (<de-docref CY="DE" DNUM="4433827" KI="A1">DE 44 33 827 A1</de-docref>) have not led to more precise measurement results than the aforementioned methods, which are already relatively time-consuming and computationally intensive. With this effort, the procedures are only of limited suitability for routine and preventive examinations. In particular, the determination of the oxygen saturation at every point of a two-dimensional, photographic image, which is of interest for clinical practice, requires a method that is fast on the one hand, but on the other hand compensates for optical and spectrometric disturbances from the vascular environment.
The invention is therefore based on the object of nevertheless determining the oxygen saturation in a method which is as simple and fast as possible with high accuracy.
This object is achieved by a method for determining the oxygen saturation of blood with the features specified in claim 1.
It is advantageous if the spectral measured values and reference data are recorded logarithmically and the auxiliary and reference functions are each formed by a straight line on which two of the measured or reference values for isosbestic wavelengths lie. The correction function formed from the linear auxiliary and reference functions gives rise to a likewise linear corrected auxiliary function of the corrected measurement spectrum. The remaining spectral measurements, ie the spectral measured value for the third isosbestic wavelength and the other measured value, at a wavelength at which the reference values of hemoglobin and oxyhemoglobin differ as widely as possible in the reference spectra, are applied with a constant multiplier, which is determined in this way, that the third isosbestic measurement value of the corrected measurement spectrum corrected by this stretching corresponds to the corresponding reference value of the reference spectra. In this special case, the difference between the reference values for hemoglobin and oxyhemoglobin can be scaled linearly between 0 and 1. The oxygen saturation of the blood is determined in relation to this scale from the other measured value converted to the corrected auxiliary function of the corrected measurement spectrum.
For a clear two-dimensional representation of the oxygen saturation of the blood, four monochromatic single images are generated at the wavelengths and the oxygen saturation determined for each pixel.
Surprisingly, it has been shown that the proposed method can be used to determine the oxygen saturation of the blood with the same accuracy, but with significantly less effort (at least four measured values required) for measurement, calculation and evaluation in comparison to the examination methods mentioned at the beginning. The method enables a two-dimensional location-dependent representation of the measurement results for clear and quick evaluation. It only requires a few measurements and only uses linear transformations. With these advantages of low effort and time-effective measurement evaluation, the proposed method is also suitable for screening and for routine or preventive examinations.
The invention will be explained below with reference to an embodiment shown in the drawing.
Show it:
<figref idref="S12">1</figref>: Diagram with spectral measurement and reference values in logarithmic representation in the wavelength range between 400 nm and 700 nm, including three isosbestic wavelengths λ<sub>i1</sub> = 522 nm, λ<sub>i2</sub> = 586 nm, λ<sub>i3</sub> = 569 nm and the other wavelength λ<sub>a</sub> = 555 nm
<figref idref="S12">2</figref>: Diagram with spectral reference values according to <figref idref="S12">1</figref> with linear reference function F shown<sub>R</sub> as well as with corrected measured values M '
<figref idref="S13">3</figref>: Diagram with spectral reference values according to <figref idref="S12">1</figref> with linear reference function F shown<sub>R</sub>, with corrected measured values M '' and with scaling for reading the oxygen saturation
The reflection or transmission of tissue in one place or with local resolution in an image is at three isosbestic wavelengths λ<sub>i1</sub>, λ<sub>i2</sub> and λ<sub>i3</sub> (λ<sub>i1</sub> = 522 nm, λ<sub>i2</sub> = 586 nm, λ<sub>i3</sub> = 569 nm) as measurement data M<sub>i1</sub>, M<sub>i2</sub> and M<sub>i3</sub> as well as at a different wavelength λ<sub>a</sub> (555 nm), in which the absorption coefficients of oxygenated and reduced hemoglobin differ, as the measured value M<sub>a</sub> measured and with the reflection or transmission of hemoglobin or whole blood with oxygen saturations of 0% and 100% at these wavelengths (reference data R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, <de-math>R<chf>0%<chfbr type="none">α</chfbr></chf> and R<chf>100%<chfbr type="none">α</chfbr></chf>)</de-math> compared according to the following procedure: <ul><li>1. All measurement and reference data are logarithmic. <figref idref="S12">1</figref> shows the measurement and reference data in logarithmic representation, in this example the reflection of a retinal vein (measurement data) and the transmission of a 0.1 mm thick layer of whole blood (reference data). For the sake of clarity, the complete spectra between 400 nm and 700 nm are shown. The wavelengths λ used in this example<sub>i1</sub> = 522 nm, λ<sub>i2</sub> = 586 nm, λ<sub>i3</sub> = 569 nm and λ<sub>a</sub> = 555 nm are shown.</li><li>2nd A linear auxiliary function F<sub>H</sub> the wavelength is calculated in the measurement spectrum so that its values at the isosbestic wavelengths λ<sub>i1</sub> and λ<sub>i1</sub> with the measurement data M<sub>i1</sub> and M<sub>i2</sub> agree at these wavelengths.</li><li>3rd A linear reference function F<sub>R</sub> of the wavelength is calculated in the reference spectra so that their values at the isosbestic wavelengths λ<sub>i1</sub> and λ<sub>i2</sub> with the reference data R<sub>i1</sub> and R<sub>i2</sub> agree at these wavelengths.</li><li>4th The measurement data are at each wavelength by the difference of the linear functions F<sub>H</sub> and F<sub>R</sub> additively corrected so that at the isosbestic wavelengths λ<sub>i1</sub> and λ<sub>i2</sub> agree with the reference data: M '<sub>λ</sub> = M<sub>λ</sub> + F<sub>R</sub> - F<sub>H</sub>. <br /><figref idref="S12">2</figref> again shows the reference data, the linear reference function F<sub>R</sub> the wavelength and the corrected measurement data M '. In addition to the absorption of hemoglobin, this correction compensates for existing extinctions whose spectra in the wavelength range 522 nm to 586 nm can be assumed or approximated as linear on a logarithmic scale. In the exemplary embodiment considered here, these are the absorptions of the melanin and the front eye media as well as the scatter in the blood and in the surrounding tissue.</li><li>5. The corrected measurement data M 'are thus around the linear reference function F<sub>R</sub> stretched or compressed that at the isosbestic wavelength λ<sub>i3</sub> with the reference value R<sub>i3</sub> to match: <de-figure num="1"><img file="DE10217543B4_D0001.tif" /></de-figure><figref idref="S13">3</figref> shows the spreading (possibly also compression) resulting in M ″ of the corrected measurement data M ′ around the linear reference function F<sub>R</sub>, which is carried out in such a way that corrected measurement data and reference data at the isosbestic wavelength λ<sub>i3</sub> (569 nm) match. This correction compensates for different absolute values of the measurement and reference data that arise from different lighting and measurement conditions.</li><li>6. The location of M ''<sub>a</sub> on a linear between <de-math>R<chf>0%<chfbr type="none">α</chfbr></chf> and R<chf>100%<chfbr type="none">α</chfbr></chf></de-math> spanned scale indicates the oxygen saturation OS: <de-figure num="1"><img file="DE10217543B4_D0002.tif" /></de-figure></li></ul>
The scaled reading of the oxygen saturation (OS) between the values 0 and 1 is also in <figref idref="S13">3</figref> shown. The oxygen saturation OS read is 0.69 in the exemplary embodiment.
List of the reference numerals used
<ul><li><dl><dt>M</dt><dd>- measurement data</dd><dt>M '</dt><dd>- Measurement data corrected by adding the corrected auxiliary function</dd><dt>M ''</dt><dd>- Measurement data M 'corrected by applying a factor</dd><dt>F<sub>R</sub></dt><dd>- reference function</dd><dt>OS</dt><dd>- oxygen saturation</dd><dt>λ</dt><dd>- wavelength</dd></dl></li></ul>
5 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5
Every citation, both waysCites: the store holds 9 of 10
| Document | Relation | Office | Cited during |
|---|---|---|---|
| DE19920157A1 | Cites | Germany | Search report |
| US4253744A | Cites | United States of America | Search report |
| US4305398A | Cites | United States of America | Search report |
| DE4433827A1 | Cites | Germany | Search report |
| US4485820A | Cites | United States of America | Search report |
| US5119814A | Cites | United States of America | Search report |
| US5308919A | Cites | United States of America | Search report |
| US5318022A | Cites | United States of America | Search report |
| US5776060A | Cites | United States of America | Search report |
| DELORI, F.C.: Noninvasive technique for oximetry of blood in retinal vessels, In: Appl. Opt. 27, 1988, S. 113-1125 | Non-patent | – | Search report |
| HAMMER, M. et al.: Light paths in retinal vessel oximetry, In: IEEE Trans. Biomed. Eng. 48(5), 2001, 592-598 | Non-patent | – | Search report |
| PITTMANN, R.N., DULING, B.R.: A new method for the measurement of percent oxyhemoglobin, J. Appl. Physiol. 38, 1975, S. 315-320 | Non-patent | – | Search report |
| SCHWEITZER, D. et al.: In vivo measurement of the oxygen Saturation at the normal eye, In: Appl. Opt. 27, 1988, S. 113-1125 | Non-patent | – | Search report |
| SMITH at al.: Effect of multiple light paths in retinal vessel oximetry, In: Appl. Opt. 39, 2000, S. 1183-1193 | Non-patent | – | Search report |
| TWERSKY, V.: Absorption and multiple scattering by biological suspensions, In: J. Opt. Society of America 60, 1970, S. 1084-1093 | Non-patent | – | Search report |
| DELORI, F.C.: Noninvasive technique for oximetry of blood in retinal vessels, In: Appl. Opt. 27, 1988, S. 113-1125 | Non-patent | – | – |
| HAMMER, M. et al.: Light paths in retinal vessel oximetry, In: IEEE Trans. Biomed. Eng. 48(5), 2001, 592-598 | Non-patent | – | – |
| PITTMANN, R.N., DULING, B.R.: A new method for the measurement of percent oxyhemoglobin, J. Appl. Physiol. 38, 1975, S. 315-320 | Non-patent | – | – |
| SCHWEITZER, D. et al.: In vivo measurement of the oxygen Saturation at the normal eye, In: Appl. Opt. 27, 1988, S. 113-1125 | Non-patent | – | – |
| SMITH at al.: Effect of multiple light paths in retinal vessel oximetry, In: Appl. Opt. 39, 2000, S. 1183-1193 | Non-patent | – | – |
| TWERSKY, V.: Absorption and multiple scattering by biological suspensions, In: J. Opt. Society of America 60, 1970, S. 1084-1093 | Non-patent | – | – |
6 members in 3 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 10217543 | Germany | A | |
| DE2002117543 | – | – | – |
Members6
| Document | Office | Kind | |
|---|---|---|---|
| WO03086193A1 | World Intellectual Property Organization (WIPO) | A1 | |
| DE10217543A1 | Germany | A1 | |
| US2006063994A1 | United States of America | A1 | |
| US7333842B2 | United States of America | B2 | |
| US2008194931A1 | United States of America | A1 | |
| DE10217543B4This record | Germany | B4 |
5 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | |
| Patent grant now finalGrantedR020 | R020 | |
| Grant decision by examination section/examining divisionR018 | R018 | |
| Request for examination paragraph 448110 | 8110 | |
| New person/name/address of the applicant8127 | 8127 |
Numbers
- Publication
- 10217543
- Publication, DOCDB
- 10217543
- Publication, EPODOC
- DE10217543
- Application
- 10217543
- Application, DOCDB
- 10217543
- Application, EPODOC
- DE2002117543
Titles2
- German
- Verfahren zur spektrometrischen Bestimmung der Sauerstoffsättigung von Blut in Gegenwart optischer Störgrößen
- English
- Method for the spectrometric determination of the oxygen saturation of blood in the presence of optical disturbances
Classification
- CPC, 2
- A61B5/14551
- A61B5/14555
- IPC, 6
- A61B5 145
- A61B3 12
- A61B5 00
- G01N21 47
- G01N21 55
- G01N33 49